Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre L Triozzi

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
JAMA Ophthalmology|November 6, 2015
Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma PrognosisIsabel Schuermeyer, Anca Maican, Richard Sharp, et al.
Molecular Immunology|December 28, 2013
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic diseaseSusan Achberger, Wayne Aldrich, Raymond Tubbs, et al.
Journal of Translational Medicine|December 11, 2012
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferonPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Clinical Epigenetics|July 26, 2016
Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanomaPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Vaccine|January 18, 2005
A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF)Jose Lima, Connie Jenkins, Antonio Guerrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survivalHong M Moulton, Paul H Yoshihara, David H Mason, et al.
Oncoimmunology|October 25, 2019
Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytesPierre L Triozzi, Lynn Schoenfield, Thomas Plesec, et al.
Clinical & Experimental Metastasis|August 28, 2016
Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cellsPowrnima Joshi, Mitra Kooshki, Wayne Aldrich, et al.
International Journal of Cancer|September 30, 2004
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesotheliomaPierre L Triozzi, Wayne Aldrich, Karen O Allen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapsePierre L Triozzi, Wayne Aldrich, Karen O Allen, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
JAMA Ophthalmology|November 6, 2015
Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma PrognosisIsabel Schuermeyer, Anca Maican, Richard Sharp, et al.
Molecular Immunology|December 28, 2013
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic diseaseSusan Achberger, Wayne Aldrich, Raymond Tubbs, et al.
Journal of Translational Medicine|December 11, 2012
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferonPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Clinical Epigenetics|July 26, 2016
Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanomaPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Vaccine|January 18, 2005
A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF)Jose Lima, Connie Jenkins, Antonio Guerrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survivalHong M Moulton, Paul H Yoshihara, David H Mason, et al.
Oncoimmunology|October 25, 2019
Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytesPierre L Triozzi, Lynn Schoenfield, Thomas Plesec, et al.
Clinical & Experimental Metastasis|August 28, 2016
Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cellsPowrnima Joshi, Mitra Kooshki, Wayne Aldrich, et al.
International Journal of Cancer|September 30, 2004
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesotheliomaPierre L Triozzi, Wayne Aldrich, Karen O Allen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapsePierre L Triozzi, Wayne Aldrich, Karen O Allen, et al.
Pageof 6